Literature DB >> 9378397

Sleep and gastric function in irritable bowel syndrome: derailing the brain-gut axis.

W C Orr1, M D Crowell, B Lin, M J Harnish, J D Chen.   

Abstract

BACKGROUND: Recently, several studies have shown an alteration in bowel function during sleep in patients with irritable bowel syndrome (IBS), and a recent study also suggests a remarkable increase in rapid eye movement (REM) sleep. These studies have suggested that an alteration in CNS function may play an important role in the pathogenesis of IBS. AIMS: To confirm the presence of an alteration in REM sleep in patients with IBS and to assess the relation between sleep and a non-invasive measure of gastric functioning, the electrogastrogram (EGG). PATIENTS: Ten patients with IBS and 10 age and sex matched normal volunteers.
METHODS: All subjects slept one night in the sleep laboratory and underwent polysomnographic monitoring to determine sleep patterns, and recording of the EGG from surface electrodes.
RESULTS: The IBS group had a notable and significant increase in the percentage and duration of REM sleep (p < 0.05). The control group had a decrease in the amplitude of the dominant EGG frequency from waking to non-REM sleep (p < 0.05), and a subsequent increase in the amplitude from non-REM to REM sleep (p < 0.05). No such changes were noted in the patients with IBS.
CONCLUSIONS: Results confirmed the enhancement of REM sleep in patients with IBS and suggested an intrinsic alteration in autonomic and CNS functioning in patients with IBS.

Entities:  

Mesh:

Year:  1997        PMID: 9378397      PMCID: PMC1891498          DOI: 10.1136/gut.41.3.390

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline.

Authors:  J C Gillin; R J Wyatt; D Fram; F Snyder
Journal:  Psychopharmacology (Berl)       Date:  1978-12-08       Impact factor: 4.530

2.  What is measured in electrogastrography?

Authors:  A J Smout; E J van der Schee; J L Grashuis
Journal:  Dig Dis Sci       Date:  1980-03       Impact factor: 3.199

3.  REM phase deprivation and schizophrenia II.

Authors:  V Zarcone; K Azumi; W Dement; G Gulevich; H Kraemer; T Pivik
Journal:  Arch Gen Psychiatry       Date:  1975-11

4.  Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome.

Authors:  P Welgan; H Meshkinpour; M Beeler
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

5.  Sham feeding. Cephalic-vagal influences on gastric myoelectric activity.

Authors:  R M Stern; H E Crawford; W R Stewart; M W Vasey; K L Koch
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

6.  Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome.

Authors:  R C Smith; D S Greenbaum; J B Vancouver; R C Henry; M A Reinhart; R B Greenbaum; H A Dean; J E Mayle
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

7.  Improvement of depression by REM sleep deprivation. New findings and a theory.

Authors:  G W Vogel; F Vogel; R S McAbee; A J Thurmond
Journal:  Arch Gen Psychiatry       Date:  1980-03

8.  Functional bowel disorders in apparently healthy people.

Authors:  W G Thompson; K W Heaton
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

Review 9.  Motility disorders and stress.

Authors:  M Camilleri; M Neri
Journal:  Dig Dis Sci       Date:  1989-11       Impact factor: 3.199

10.  Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples.

Authors:  W E Whitehead; L Bosmajian; A B Zonderman; P T Costa; M M Schuster
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more
  17 in total

1.  Inhibitory reflexive effect of rectal distension on postprandial gastric myoelectrical activity.

Authors:  Liwei Qian; William C Orr; J D Z Chen
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

2.  Intestinal malabsorption as a manifestation of obstructive sleep apnea.

Authors:  Tamsin A Knox; Tawhid Gazi; Fay Kastrinos; Alexander C White
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

3.  Melatonin: a novel treatment for IBS?

Authors:  S Elsenbruch
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

4.  Impaired circadian rhythm of gastric myoelectrical activity in patients with multiple system atrophy.

Authors:  Atsuya Suzuki; M Asahina; C Ishikawa; K M Asahina; K Honma; T Fukutake; T Hattori
Journal:  Clin Auton Res       Date:  2005-12       Impact factor: 4.435

5.  Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome.

Authors:  M Jarrett; M Heitkemper; K C Cain; R L Burr; V Hertig
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

Review 6.  Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review.

Authors:  F A Luscombe
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

7.  Conditioned pain modulation in women with irritable bowel syndrome.

Authors:  Monica E Jarrett; Robert J Shulman; Kevin C Cain; Wimon Deechakawan; Lynne T Smith; Philippe Richebé; Margaret Eugenio; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2014-01-24       Impact factor: 2.522

8.  Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population.

Authors:  F Cremonini; M Camilleri; A R Zinsmeister; L M Herrick; T Beebe; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2008-09-18       Impact factor: 3.598

Review 9.  Role of serotonin in the pathophysiology of the irritable bowel syndrome.

Authors:  Michael D Crowell
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

Review 10.  Melatonin for the treatment of irritable bowel syndrome.

Authors:  Kewin Tien Ho Siah; Reuben Kong Min Wong; Khek Yu Ho
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.